Presented by Real Chemistry
Patient-Centricity Reduces Healthcare Inequality
The CDC has reported increasing evidence that some racial and ethnic minority groups are being disproportionately affected by COVID-19. Factors such as poverty, lack of access to healthcare and poor housing conditions contributed to this inequity. Patient-centric solutions in healthcare have the power to help reduce this inequality. Looking holistically at a patient’s journey requires navigating the impacts of race, gender, ethnicity and religion. This deep understanding of the patient experience supports development of innovative solutions and behavioral drivers of care. This panel will explore the importance of involving diverse patient voices in conversations around clinical trials, drug development, and advances in specific disease areas.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Anya Harry
GlaxoSmithKline
Abby Hayes
W2O
Mary Michael
Otsuka America Pharmaceutical Inc
Mary Stutts
Sumitovant Biopharma